Monica Katyal
YOU?
Author Swipe
View article: Impact of jail-based methadone or buprenorphine treatment on non-fatal opioid overdose after incarceration
Impact of jail-based methadone or buprenorphine treatment on non-fatal opioid overdose after incarceration Open
View article: Jail-based medication for opioid use disorder and patterns of reincarceration and acute care use after release: A sequence analysis
Jail-based medication for opioid use disorder and patterns of reincarceration and acute care use after release: A sequence analysis Open
View article: Transitions of care between jail-based medications for opioid use disorder and ongoing treatment in the community: A retrospective cohort study
Transitions of care between jail-based medications for opioid use disorder and ongoing treatment in the community: A retrospective cohort study Open
Background and Aims Offering medications for opioid use disorder (MOUD) in carceral settings can significantly reduce overdose risk. However, it is unknown whether and to what extent individuals in U.S. jail settings continue MOUD once the…
View article: Association between jail‐based methadone or buprenorphine treatment for opioid use disorder and overdose mortality after release from New York City jails 2011–17
Association between jail‐based methadone or buprenorphine treatment for opioid use disorder and overdose mortality after release from New York City jails 2011–17 Open
Background and aims Opioid overdose is a leading cause of death during the immediate time after release from jail or prison. Most jails in the United States do not provide methadone and buprenorphine treatment for opioid use disorder (MOUD…
View article: Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail
Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail Open
ClinicalTrials.gov Identifier: NCT03604159.
View article: COVID-19 in the New York City Jail System: Epidemiology and Health Care Response, March–April 2020
COVID-19 in the New York City Jail System: Epidemiology and Health Care Response, March–April 2020 Open
Objectives People detained in correctional facilities are at high risk for infection with severe acute respiratory syndrome coronavirus 2, the virus that causes coronavirus disease 2019 (COVID-19). We described the epidemiology of the COVI…
View article: Effectiveness and safety of ipilimumab therapy in advanced melanoma: evidence from clinical practice sites in the US
Effectiveness and safety of ipilimumab therapy in advanced melanoma: evidence from clinical practice sites in the US Open
he incidence of melanoma, the most serious form of skin cancer, is rising globally. 1,2lthough most patients are diagnosed and treated at an early stage of the disease and have a good prognosis, survival among patients with unresectable or…